India Pharma Stocks Plunge After U.S. Drug Pricing Revelations

Nov 04, 2016

Indian pharmaceutical stocks reportedly plunged because of growing concerns about pressures on drug prices there after revelations from a Justice Department probe, according to a Bloomberg article. India's pharma companies are collectively the second-biggest suppliers of generic medicines to the U.S.

Sun Pharmaceutical Industries Ltd., the only Indian firm to have disclosed receiving a subpoena from the Department of Justice, fell 5.1 percent, the story said, and Dr. Reddy’s Laboratories Ltd., India’s second largest by sales, fell 4.9 percent.

Read the Bloomberg article

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments